Table 2. Effect of MB/MV Analogues (1–5) on the Cellular Viability of Primary FRDA Fibroblasts against Erastin-Induced Ferroptotic Cell Deatha.
| Compound | Erastin challenge cell survival EC50 (nM) |
|---|---|
| MB | 43 ± 3 |
| MV | 27 ± 3 |
| 1a | 39 ± 3 |
| 1b | 15 ± 2 |
| 2a | 37 ± 3 |
| 2b | 11 ± 1 |
| 3a | 29 ± 3 |
| 3b | 10 ± 1 |
| 4a | 35 ± 1 |
| 4b | 15 ± 1 |
| 5a | 55 ± 6 |
| 5b | 22 ± 2 |
| Lip-1 | 22 ± 4 |
| Fer-1 | 33 ± 4 |
| α-TOH | >500 |
The calculated EC50 values were determined graphically from the dose–response curves using the nonlinear regression curve fit analysis model.